No Forward Throw: Protecting What Lies Beyond The Target
Nov 19, 2026
Breast biopsy is a procedure performed at depth, often within a centimetre or two of the chest wall, an implant capsule or the skin. In that space, the distance a needle travels beyond its intended target is not a technicality. It is the difference between a safe biopsy and an avoidable complication.
The Pain Point: The Millimetres Nobody Plans For
Spring-loaded biopsy devices work by firing. The stylet advances into the lesion and the cannula then fires forward over it, and in many designs the whole assembly travels a further centimetre or two at speed. That forward travel is intentional, because it produces the cut. It is also the part of the procedure that the operator cannot fully control once the trigger is pressed.
In a breast with generous tissue and a lesion well away from the chest wall, the extra travel is harmless. In a thin breast, a lesion against the pectoralis, a lesion adjacent to a breast implant, or a lesion close to the skin, it is not. The consequences range from the mundane, such as a bruised chest wall or a more painful recovery, to the serious, such as implant puncture or a track that enters the pleural space.
Operators manage this risk with trajectory planning, which is the correct primary defence. But trajectory planning assumes the device behaves as predicted, and the distance a device throws is a design property that is rarely stated plainly in a brochure.
Principles: Where the Throw Comes From
A firing mechanism stores energy in a spring and releases it to drive the cannula forward. The designer chooses how much travel is needed to shear a specimen of the desired length, and that travel becomes the device's throw. A longer throw yields a longer core, which is why large-core devices often have longer travel than fine ones.
The alternative is to capture tissue without advancing the whole assembly. In a no-forward-throw design, the stylet and notch are positioned at the lesion, and the cutting is achieved by advancing the cannula over the notch while the tip remains essentially stationary relative to the target. The specimen is still cut, but the instrument does not lunge beyond the planned depth.
The clinical consequence is predictability. The operator can plan a trajectory that ends a few millimetres short of a structure and trust that the instrument will not travel past it. This matters most where the margin for error is smallest, and it is why the feature is valued in breast work rather than treated as a marketing preference.
There is a trade-off to acknowledge. A device with no forward travel may require a slightly different technique, and its core length may be determined by notch geometry rather than by throw. Departments adopting such a device should expect a short learning period, and should evaluate core length and specimen quality rather than assuming equivalence.
Device Types and Their Safety Profiles
Spring-loaded core needles with forward throw are the most widely used devices for ultrasound-guided breast biopsy. They are fast, effective and inexpensive per procedure. Their safety profile depends on planning: the trajectory must allow for the throw, and the operator must know the device's travel distance.
Vacuum-assisted devices draw tissue into a window and cut it with a rotating or reciprocating cutter. Their forward travel is usually modest, and the multiple-sample capability reduces the number of insertions. They are the preferred option for calcifications and for lesions where a single insertion is desirable.
No-forward-throw core devices are designed for depth-sensitive anatomy, including lesions near the chest wall, subareolar lesions, and cases involving implants. Their value is not that they are safer in the abstract, but that they remove a variable the operator would otherwise have to accommodate.
Fine needle aspiration sits outside this discussion. It uses suction and a narrow needle, involves no firing, and is appropriate for selected targets. Its limitation is specimen type rather than mechanism, which is why it has not replaced core biopsy for image-detected lesions.
Practical Guidance for Depth-Sensitive Cases
Plan the trajectory before choosing the device. Use ultrasound to measure the distance from the skin to the lesion, the lesion's thickness, and the distance from the lesion to the chest wall, the implant capsule and the skin surface. If the available margin is smaller than the device's throw, the device is the wrong choice regardless of gauge.
Approach parallel to the chest wall wherever the anatomy allows, so that any unintended travel runs along the plane rather than into it. For lesions close to an implant, confirm the capsule's position and keep the needle entirely within breast tissue; a no-forward-throw device is often the safer default in this setting.
Have a fallback. If the planned device cannot be used safely, the alternatives are a vacuum-assisted device, a finer gauge with a shorter throw, or a different approach such as a periareolar route. Deciding this before the patient is draped avoids the situation where the only option is to proceed and hope.
Document the device, the gauge, the throw and the number of passes. If a complication occurs, this record is the difference between a reviewable event and an unexplained one. It also allows a department to compare devices on something other than impressions.
Depth also changes the choice of needle length. A device that is too short may require the operator to press the breast to bring the lesion closer, which distorts the anatomy and shortens the measured margin. A longer needle lets the breast remain in its natural position, so the distance measured on ultrasound is the distance the needle actually travels. In depth-sensitive cases, length and mechanism matter as much as gauge, and all three should be confirmed before the tray is opened.
Experience: Cases That Change Practice
The most instructive cases are the ones where the anatomy was visible on imaging but not accounted for in planning. A lesion deep in a thin breast, a target adjacent to a subpectoral implant, a marker clip placed close to the skin: each is a situation where the operator's attention is on the target and the device is quietly adding distance beyond it.
Experienced operators describe a shift in attention after such a case. They begin to measure the margin, not just the depth, and they choose devices by what lies beyond the lesion rather than by what lies within it. That shift is small and permanent, and it is how a service matures.
They also learn to value visibility. A device whose notch is clearly marked on ultrasound allows the operator to confirm the position before cutting, which reduces the temptation to fire early and accept a marginal sample. Visibility and safety are related features, not separate ones.
Summary
Forward travel is a design property with clinical consequences. Where the anatomy provides margin, it is a convenience; where it does not, it is a risk that must be planned around. No-forward-throw designs remove the risk by keeping the cutting action at the target rather than beyond it.
The practical rule is simple: measure the margin, choose the mechanism, then choose the gauge. A department that measures margins will find that device selection becomes a clinical decision rather than a purchasing one, and that complications become events with explanations rather than surprises.
Outlook: Safety by Design
Breast intervention is moving toward office-based, image-guided procedures with less tissue removed and more attention to the patient's experience. In that setting, devices that behave predictably at depth will have an advantage, because predictability is what allows a procedure to be performed safely outside an operating theatre.
Expect mechanism transparency to become a purchasing criterion: stated throw, stated notch length, stated travel. A supplier that can describe these numbers is a supplier that understands what the operator is managing, and that is the beginning of a useful conversation.







